Physician profile
Pramod Kumar
NPI 1942514203
$3,268.52
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $624 · 2021: $1,248 · 2022: $560.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $719.87 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $427.32 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $361.62 | 2019-2021 | |
| Redhill Biopharma INC. | $239.19 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $211.61 | 2019-2021 | |
| Pfizer INC. | $198.31 | 2019-2021 | |
| Lilly USA, LLC | $174.04 | 2020-2022 | |
| Mdd US Operations, LLC | $149.44 | 2019 | |
| Assertio Therapeutics, INC. | $115.46 | 2019 | |
| Si-Bone, INC. | $95.49 | 2019-2021 | |
| Boston Scientific Corporation | $88.27 | 2019-2020 | |
| Nevro Corp. | $87.47 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $82.59 | 2021 | |
| Mallinckrodt Enterprises LLC | $60.25 | 2019 | |
| Medtronic USA, INC. | $51.75 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $44.94 | 2020 | |
| Novo Nordisk INC | $33.00 | 2022 | |
| Relievant Medsystems, INC. | $29.14 | 2020 | |
| Pacira Therapeutics, INC. | $26.23 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $23.31 | 2019 | |
| Shionogi INC | $19.78 | 2019 | |
| Flowonix Medical Incorporated | $16.65 | 2019 | |
| Daiichi Sankyo INC. | $12.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramod Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.